Skip to main content
. 2021 Jan 5;162(4):377–388. doi: 10.1111/imm.13272

TABLE 1.

Advantages and disadvantages of different species as preclinical models of trauma

Advantages Disadvantages Immune cell composition (%) Common uses in trauma research
Mice
  • Inexpensive

  • Easy to handle

  • Huge variety of genetic knock‐in/knockouts available

  • Large cohorts

  • Rapid breeding cycle

  • Broad availability of biological reagents

  • Small TBV (relative to large animals)

  • Difficult to manipulate

  • Genetically the most different from humans

  • Short life span

  • Neutrophils: 10%–25%

  • Lymphocytes: 50%–90%

  • Monocytes: 1%–4%

  • Drug metabolism and screening

  • Mechanistic studies (i.e. transgenic mice)

  • Traumatic brain injury

  • Wound healing

Rat
  • Inexpensive

  • Easy to handle

  • Some genetic knock‐in/knockouts available

  • Large cohorts

  • Broad variability of biological reagents

  • Small TBV (relative to large animals)

  • Short life span

  • Neutrophils: 4%–20%

  • Lymphocytes: >70%

  • Monocytes: 1%–4%

  • Haemorrhagic shock

  • Wound healing

  • Toxicology

  • Mechanistic studies

Rabbit
  • Large TBV (relative to rodents)

  • Inexpensive (relative to large animal models)

  • Bone physiology similar to humans

  • Superior humoral immune responses

  • Comparable neutrophil responses to humans

  • Long life span (relative to rodents)

  • Challenging to find biological reagents

  • Genetically more similar to humans that rodents

  • Neutrophils: >30%

  • Lymphocytes: 60‐70%

  • Monocytes: 1%–5%

  • Fracture and traumatic bone injury

  • Drug metabolism

  • Haemorrhagic shock

  • Tissue injury

Pig
  • Large TBV

  • Some cross‐reactivity with human reagents

  • Comparable lymphoid structures to humans

  • Long life span (relative to rodents)

  • Complex medical equipment required

  • Challenging to produce large cohorts

  • Challenging to find biological reagents

  • Neutrophils: 20%–45%

  • Lymphocytes: 30%–70%

  • Monocytes: 1%–10%

  • Haemorrhagic shock

  • Fluid resuscitation

  • Tissue injury

  • Coagulopathy

Sheep
  • Large TBV

  • Bone physiology similar to humans’ long life span (relative to rodents)

  • Complex medical equipment required

  • Challenging to produce large cohorts

  • Challenging to find biological reagents

  • Neutrophils: 25%–30%

  • Lymphocytes: 60%–70%

  • Monocytes: 1%–6%

  • Coagulopathy

  • Fracture and traumatic bone injury

Goat
  • Large TBV

  • Bone physiology similar to humans

  • Long life span (relative to rodents)

  • Complex medical equipment required

  • Challenging to produce large cohorts

  • Challenging to find biological reagents

  • Neutrophils: 25%–30%

  • Lymphocytes: 60%–70%

  • Monocytes: 1%–10%

  • Fracture and traumatic bone injury

Non‐human primates
  • Large TBV

  • Immune responses

  • Broad cross‐reactivity with human reagents

  • Long life span (relative to rodents)

  • Complex medical equipment required

  • Less ethically accepted

  • Challenging to produce large cohorts

  • Neutrophils: 40%–60%

  • Lymphocytes: 30%–50%

  • Monocytes: 1%–4%

  • Haemorrhagic shock

  • Fluid resuscitation

  • Coagulopathy